US Patent 11752217 Hydrogel prodrug for treatment
Patent 11752217 was granted and assigned to Viking Scientific, Inc. on September, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11752217 Hydrogel prodrug for treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
